Corvus Pharma (NASDAQ:CRVS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Corvus Pharma (CRVS) operate in?

Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Corvus Pharma Stock (NASDAQ: CRVS) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 218.52K
Day Range	- - -
52 Wk Range	1.05 - 2.86
Market Cap	$136.36M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	2.84%
Days to Cover	6.53

Recent News

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading.

Avi Kapoor

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for alternatives to safes made by Liberty Safe.

Lisa Levin

Corvus Pharmaceuticals Eyes Expansion Of Blood Cancer Therapy but Resource Limitations Pose Challenge: Oppenheimer

Oppenheimer has initiated coverage on Corvus Pharmaceuticals Inc (NASDAQ: CRVS) with an Outperform rating and a

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Corvus Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and ant...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Corvus Pharma (CRVS) stock?

You can purchase shares of Corvus Pharma (NASDAQ:CRVS) through any online brokerage.

View our list of the best stock brokerages

Who are Corvus Pharma (CRVS) competitors?

Other companies in Corvus Pharma’s space includes: Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), Tevogen Bio Holdings (NASDAQ:TVGN), Agenus (NASDAQ:AGEN) and FibroBiologics (NASDAQ:FBLG).

What is the target price for Corvus Pharma (CRVS) stock?

There is no analysis for Corvus Pharma.

What is the forecast for Corvus Pharma (CRVS) stock?

Corvus Pharma has a consensus price target of $6.83.

Current stock price for Corvus Pharma (CRVS)?

The stock price for Corvus Pharma (NASDAQ: CRVS) is $2.18 last updated July 19, 2024 at 4:00 PM EDT.

Does Corvus Pharma (CRVS) pay a dividend?

There are no upcoming dividends for Corvus Pharma.

When is Corvus Pharma (NASDAQ:CRVS) reporting earnings?

Corvus Pharma’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is Corvus Pharma (CRVS) going to split?

There is no upcoming split for Corvus Pharma.

What sector and industry does Corvus Pharma (CRVS) operate in?

Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Corvus Pharma

Corvus Pharma (CRVS) Forecast